femoston conti 0.5mg/2.5mg film-coated tablets
viatris healthcare limited damastown industrial park, mulhuddart, dublin 15, dublin , ireland - film-coated tablet - dydrogesterone 2.5 mg estradiol 0.5 mg - sex hormones and modulators of the genital system
femoston 1/10 1 mg, 10 m milligram film coated tablet
abbott healthcare products ltd - estradiol hemihydrate dydrogesterone - film coated tablet - 1 mg, 10 m milligram
femoston 2/10 2 mg, 10 m milligram film coated tablet
abbott healthcare products ltd - estradiol hemihydrate dydrogesterone - film coated tablet - 2 mg, 10 m milligram
femoston-conti 0.5mg/2.5mg, film-coated tablets
mylan products limited - dydrogesterone; estradiol - film-coated tablet - dydrogesterone 2.5 mg; estradiol 0.5 mg - sex hormones and modulators of the genital system
femoston-conti 0.5/2.5 milligram film coated tablet
abbott healthcare products ltd - estradiol dydrogesterone - film coated tablet - 0.5/2.5 milligram
femoston conti 0.5mg/2.5mg film-coated tablets
bgp products ltd - dydrogesterone 2.5 mg, estradiol 0.5 mg - film-coated tablet
femoston-conti 1mg/5mg milligram film coated tablet
abbott healthcare products ltd - estradiol dydrogesterone - film coated tablet - 1mg/5mg milligram
femoston-conti 1mg/5mg milligram film coated tablet
bgp products ltd - estradiol, dydrogesterone - film coated tablet - 1mg/5mg milligram - progestogens and estrogens, fixed combinations - : genito urinary system and sex hormones, progestogens and oestrogens, fixed combinations - hormone replacement therapy (hrt) for oestrogen deficiency symptoms in postmenopausal women at least 12 months since last menses. prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis
femoston-conti 0.5/2.5 milligram film coated tablet
bgp products ltd - estradiol, dydrogesterone - film coated tablet - 0.5/2.5 milligram - progestogens and estrogens, fixed combinations
femoston 1/10 estradiol 1mg and estradiol 1mg with dydrogesterone 10mg tablet blister pack
viatris pty ltd - estradiol, quantity: 1 mg (equivalent: estradiol hemihydrate, qty 1.03 mg); dydrogesterone, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; hypromellose; maize starch; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; ferrosoferric oxide - hormone replacement therapy (hrt) in oestrogen deficiency associated with natural or artificial menopause in women with an intact uteri. prevention of postmenopausal bone mineral density loss in women. for initiation and continuation of treatment of postmenopausal symptoms, the lowest possible effective dose for the shortest duration should be used with the goal being short term use.,hormone replacement therapy (hrt) in oestrogen deficiency associated with natural or artificial menopause in women with an intact uterus. prevention of postmenopausal bone mineral density loss in women. for initiation and continuation of treatment of postmenopausal symptoms, the lowest effective dose for the shortest duration should be used with the goal being short term use (see dosage and administration and clinical trials). when prescribed solely for the prevention of postmenopausal bone mineral density loss in women, therapy should only be prescribed for women who are at high risk of future fracture and who are intolerant of, or contraindicated for non-oestrogen products approved for prevention of osteoporosis. life style modifications and the risk benefit profile of femoston should be taken into careful consideration and discussed with the patient, to allow the patient to make an informed decision prior to prescribing( see precautions and dosage and administration).